Dosimetry Market on Track to Shine with a Valuation of US$ 4.3 Billion by 2029-FMI Projection

Dosimetry Market
Dosimetry Market

According to a recent Future Industry Insights (FMI) report, the dosimetry market would generate revenues exceeding US$ 4.3 billion by 2029 as a result of growing adoption at different healthcare facilities.

Strict government regulations regarding radiation toxicity levels, growing awareness about the harmful effect of radiation, and rising concerns about the health of employees working in environments with radiation exposure have prompted the use of dosimetry.

Rising adoption of radiopharmaceuticals used for diagnostic purposes can increase the radiation levels in hospitals. This has, in turn, increased the risk of radiation-related diseases among healthcare professionals. There has been a rise in the adoption of wearable dosimeters by hospitals to analyse radiation levels among their staff, which has created opportunity for the growth of the dosimetry market.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-3482

Key Takeaways :
•The adoption of personal electronic dosimeters for real-time monitoring is expected to gain traction, and contribute more than 60% of revenue share during the forecast period.

•Growing adoption of wearable dosimeters by hospital professionals to analyse radiation levels is expected to contribute to the significant revenue share of the segment.

•Passive dosimeters dominate the market by energy, as these are relatively cheaper than active dosimeters.

•In terms of end user, industrial and medical are expected to collectively gain more than 40% of market share during the forecast period.

•North America is the leading market, while the dosimetry market in South Asia is expected to grow at significant rate, owing to increasing healthcare infrastructure and industrialization.

Acquisition Key Strategy Followed by Leading Manufacturers.The global Dosimetry Market is expected to reach US$ 2.7 Billion in 2022, with a CAGR of 6.8% indicating positive market growth over the forecast period.
According to Future Market Insights, the Wearable Dosimetry by Modality market is expected to reach US$ 1.8 Billion in 2022, accounting for more than half of the total dosimetry market..

Want more insights on the dosimetry market?
A new study by Future Market Insights opines on the evolution of the dosimetry market from 2014 to 2021, and presents demand projections for 2022 to 2029, on the basis of product (personal electronic dosimeters, self-reading dosimeters, processed dosimeters), modality (wearable and non-wearable), energy (active dosimeters and passive dosimeters), and end user (industrial, medical, oil and gas, defence, homeland security, mining, environmental, others), across seven prominent regions.

Key Companies:

  • Honeywell
  • Fisher Scientific Inc.
  • Landauer, Inc. (Fortive)
  • Mirion Technologies Inc.
  • Fuji Electric Corporation of America
  • Polimaster Inc.
  • JP Laboratories Inc.
  • X-Z Lab Inc.
  • Ludlum Measurements Inc
  • Laurus Systems Inc.
  • Far West Technology Inc.
  • S.E. International Inc.

Unlock exclusive insights with our expert analysts:
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-3482

Dosimetry Market by Category

By Product Type :

  • Personal Electronic Dosimeter
  • Self-reading Dosimeters
  • Processed Dosimeters

By Modality :

  • Wearable
    • Collar level
    • Chest level
    • Waist level
    • Wrist level
    • Finger level
  • Non-wearable

By Energy :

  • Active Dosimeters
  • Passive Dosimeters
    • Optically Stimulated Luminescence Dosimeter (OSLD)
    • Thermoluminescence Dosimeters (TLD)
    • Radiophotoluminescence (RPL)

By End User :

  • Industrial
  • Medical
  • Oil and Gas
  • Defense, Homeland Security
  • Mining
  • Environmental
  • Others

By Region :

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle-East & Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *